These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4363475)

  • 1. Metabolic defects of primary hyperuricemia and gout.
    Wyngaarden JB
    Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of hyperuricemia in primary gout.
    Wyngaarden JB
    Trans Am Clin Climatol Assoc; 1970; 81():161-73. PubMed ID: 4331016
    [No Abstract]   [Full Text] [Related]  

  • 3. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.
    Sperling O; Wyngaarden JB; Starmer CF
    J Clin Invest; 1973 Oct; 52(10):2468-85. PubMed ID: 4353999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased PP-ribose-P synthetase activity: a genetic abnormality leading to excessive purine production and gout.
    Becker MA; Meyer LJ; Kostel PJ; Seegmiller JE
    Adv Exp Med Biol; 1973; 41():307-15. PubMed ID: 4364688
    [No Abstract]   [Full Text] [Related]  

  • 5. Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity.
    Becker MA; Meyer LJ; Wood AW; Seegmiller JE
    Science; 1973 Mar; 179(4078):1123-6. PubMed ID: 4347565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout.
    Sperling O; Eilam G; Sara-Persky-Brosh ; De Vries A
    Biochem Med; 1972 Aug; 6(4):310-6. PubMed ID: 4340256
    [No Abstract]   [Full Text] [Related]  

  • 7. Gout with purine overproduction due to increased phosphoribosylpyrophosphate synthetase activity.
    Becker MA; Meyer LJ; Seegmiller JE
    Am J Med; 1973 Aug; 55(2):232-42. PubMed ID: 4722859
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentration and synthesis of phosphoribosylpyrophosphate in erythrocytes from normal, hyperuricemic, and gouty subjects.
    Meyskens FL; Williams HE
    Metabolism; 1971 Aug; 20(8):731-42. PubMed ID: 4327978
    [No Abstract]   [Full Text] [Related]  

  • 9. On the existence of a guanine nucleotide trap, the role of adenosine kinase and a possible cause of excessive purine production in mammalian cells.
    Green H; Ishii K
    J Cell Sci; 1972 Jul; 11(1):173-7. PubMed ID: 4672340
    [No Abstract]   [Full Text] [Related]  

  • 10. Azaguanine-resistance as a manifestation of a new form of metabolic overproduction of uric acid.
    Benke PJ; Herrick N
    Am J Med; 1972 Apr; 52(4):547-55. PubMed ID: 5017247
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutant phosphoribosylpyrophosphate synthetase in two gouty siblings with excessive purine production.
    Sperling O; Persky-Brosh S; Boer P; De Vries A
    Adv Exp Med Biol; 1973; 41():299-305. PubMed ID: 4364687
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic regulation of the early steps of purine biosynthesis in Burkitt lymphoma cells and in Ehrlich ascites tumor cells.
    Reem GH
    J Pharmacol Exp Ther; 1974 Oct; 191(1):1-9. PubMed ID: 4371231
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology of purine metabolism in man.
    Kelley WN
    Enzyme; 1974; 18(3):161-75. PubMed ID: 4841658
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoxanthine-guanine phosphoribosyltransferase variant associated with accelerated purine synthesis.
    Benke PJ; Herrick N; Hebert A
    J Clin Invest; 1973 Sep; 52(9):2234-40. PubMed ID: 4353774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties.
    Sperling O; Persky-Brosh S; Boer P; De Vries A
    Biochem Med; 1973 Jun; 7(3):389-95. PubMed ID: 4351826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical biochemistry of gout].
    Greiling H
    Dtsch Med J; 1969 May; 20(10):336-41. PubMed ID: 5396909
    [No Abstract]   [Full Text] [Related]  

  • 17. Views on the pathogenesis and management of primary gout--1971.
    Gutman AB
    J Bone Joint Surg Am; 1972 Mar; 54(2):357-72. PubMed ID: 4568494
    [No Abstract]   [Full Text] [Related]  

  • 18. The kinetics of intramolecular distribution of 15N in uric acid following administration of 15N-glycine: preferential labeling of N-(3+9) of uric acid in primary gout and a reappraisal of the "glutamine hypothesis".
    Sperling O; Wyngaarden JB; Starmer CF
    Adv Exp Med Biol; 1974; 41():371-93. PubMed ID: 4832561
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of xanthine oxidase in hyperuricemic states.
    Marcolongo R; Marinello E; Pompucci G; Pagani R
    Arthritis Rheum; 1974; 17(4):430-8. PubMed ID: 4855072
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations of altered intracellular phosphoribosylpyrophosphate (PP-ribose-P) in human disease.
    Fox IH; Kelley WN
    Adv Exp Med Biol; 1974; 41():471-8. PubMed ID: 4364979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.